The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
View ORCID ProfileMaria I. Edilova, Jaclyn C. Law, Safoura Zangiabadi, Kenneth Ting, Achire N. Mbanwi, Andrea Arruda, David Uehling, Methvin Isaac, Michael Prakesch, View ORCID ProfileRima Al-awar, View ORCID ProfileMark D. Minden, Ali A. Abdul-Sater, View ORCID ProfileTania H. Watts
doi: https://doi.org/10.1101/2021.03.22.21253655
Maria I. Edilova
1Department of Immunology, University of Toronto, Toronto, ON, Canada
Jaclyn C. Law
1Department of Immunology, University of Toronto, Toronto, ON, Canada
Safoura Zangiabadi
2School of Kinesiology and Health Science, Muscle Health Research Centre (MHRC), Faculty of Health, York University, Toronto, ON, Canada
Kenneth Ting
1Department of Immunology, University of Toronto, Toronto, ON, Canada
Achire N. Mbanwi
1Department of Immunology, University of Toronto, Toronto, ON, Canada
Andrea Arruda
3Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
David Uehling
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
Methvin Isaac
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
Michael Prakesch
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
Rima Al-awar
4Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
5Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
Mark D. Minden
3Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
Ali A. Abdul-Sater
2School of Kinesiology and Health Science, Muscle Health Research Centre (MHRC), Faculty of Health, York University, Toronto, ON, Canada
Tania H. Watts
1Department of Immunology, University of Toronto, Toronto, ON, Canada
Data Availability
Drug titration data are included in supplementary tables. Flow cytometry FCS files are available from the authors upon request.
Posted March 24, 2021.
The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
Maria I. Edilova, Jaclyn C. Law, Safoura Zangiabadi, Kenneth Ting, Achire N. Mbanwi, Andrea Arruda, David Uehling, Methvin Isaac, Michael Prakesch, Rima Al-awar, Mark D. Minden, Ali A. Abdul-Sater, Tania H. Watts
medRxiv 2021.03.22.21253655; doi: https://doi.org/10.1101/2021.03.22.21253655
The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
Maria I. Edilova, Jaclyn C. Law, Safoura Zangiabadi, Kenneth Ting, Achire N. Mbanwi, Andrea Arruda, David Uehling, Methvin Isaac, Michael Prakesch, Rima Al-awar, Mark D. Minden, Ali A. Abdul-Sater, Tania H. Watts
medRxiv 2021.03.22.21253655; doi: https://doi.org/10.1101/2021.03.22.21253655
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2976)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12834)
- Forensic Medicine (12)
- Gastroenterology (835)
- Genetic and Genomic Medicine (4633)
- Geriatric Medicine (425)
- Health Economics (733)
- Health Informatics (2950)
- Health Policy (1075)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4426)
- Nursing (238)
- Nutrition (653)
- Oncology (2301)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (504)
- Public and Global Health (7020)
- Radiology and Imaging (1553)
- Respiratory Medicine (923)
- Rheumatology (447)
- Sports Medicine (386)
- Surgery (493)
- Toxicology (60)
- Transplantation (213)
- Urology (185)